Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06882785
What this trial is testing

Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia

Who this might be right for
Schizophrenia
Bristol-Myers Squibb 250
Not applicableStudy completedNCT01795326
What this trial is testing

Physician Survey on Monitoring of Patients Treated With Quetiapine

Who this might be right for
SchizophreniaBipolar DisorderMajor Depressive Disorder
AstraZeneca 800
Post-approval studies (Phase 4)Study completedNCT01140620
What this trial is testing

Effects of Ketamine and Risperidone on Cognition

Who this might be right for
Healthy VolunteersSchizophrenia
University of Manchester 87
Post-approval studies (Phase 4)Study completedNCT02298985
What this trial is testing

Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

Who this might be right for
Chronic Schizophrenia
Beersheva Mental Health Center 38
Early research (Phase 1)Study completedNCT00929955
What this trial is testing

Role of Anti-Inflammatory Agents in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 36
Early research (Phase 1)Study completedNCT06993662
What this trial is testing

The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.

Who this might be right for
AnxietyDepressionObsessive-compulsive Disorder+5 more
Rakitzi, Stavroula 107
Testing effectiveness (Phase 2)Study completedNCT01812642
What this trial is testing

A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 33
Not applicableStudy completedNCT01324973
What this trial is testing

Web-Based Weight Management for Individuals With Mental Illness

Who this might be right for
Mental DisordersSchizophreniaAffective Disorders, Psychotic+2 more
University of California, Los Angeles 60
Early research (Phase 1)Looking for participantsNCT06504290
What this trial is testing

Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119

Who this might be right for
Schizophrenia
Vigonvita Life Sciences 40
Not applicableStudy completedNCT03583203
What this trial is testing

Tobacco Intensive Motivational and Estimate Risk

Who this might be right for
Severe Mental DisorderSmoking CessationCOPD
Hospital Universitario Reina Sofia de Cordoba 230
Not applicableStudy completedNCT03005769
What this trial is testing

Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 262
Early research (Phase 1)Study completedNCT03285503
What this trial is testing

PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Beijing Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT05414058
What this trial is testing

Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes

Who this might be right for
Schizophrenia Schizoaffective
The Royal Ottawa Mental Health Centre 35
Testing effectiveness (Phase 2)WithdrawnNCT00768612
What this trial is testing

Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableUnknownNCT02964923
What this trial is testing

Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Xijing Hospital 300
Large-scale testing (Phase 3)Study completedNCT04820309
What this trial is testing

An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)

Who this might be right for
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 566
Post-approval studies (Phase 4)Study completedNCT00148564
What this trial is testing

Energy Homeostasis Under Treatment With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Charite University, Berlin, Germany 40
Not applicableStudy completedNCT03534921
What this trial is testing

Improving Diabetes Outcomes for People With Severe Mental Illness (SMI)

Who this might be right for
Diabetes Mellitus, Type 2Severe Mental Disorder
University of York 46,564
Early research (Phase 1)Study completedNCT02220712
What this trial is testing

Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd. 17
Post-approval studies (Phase 4)Study completedNCT00338949
What this trial is testing

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

Who this might be right for
SchizophreniaMetabolic Syndrome XInsulin Resistance
Veterans Medical Research Foundation 77
Next Page